155 related articles for article (PubMed ID: 2871012)
41. [Changes in the clinical picture and course of psychoses as a result of massive psychopharmacotherapy and their role in improving treatment services].
Avrutskiĭ GIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(9):1387-94. PubMed ID: 40371
[TBL] [Abstract][Full Text] [Related]
42. [Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].
Furuhashi K; Iwata N
Nihon Rinsho; 2013 Apr; 71(4):635-40. PubMed ID: 23678592
[TBL] [Abstract][Full Text] [Related]
43. Acute schizophrenia.
Johnstone EC
Br J Hosp Med; 1985 Oct; 34(4):198-201. PubMed ID: 2868766
[TBL] [Abstract][Full Text] [Related]
44. Psychotic recurrence after antipsychotic discontinuation.
Zipursky RB
Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
[No Abstract] [Full Text] [Related]
45. Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia.
Gaebel W; Riesbeck M
Schizophr Res; 2007 Sep; 95(1-3):19-29. PubMed ID: 17630253
[TBL] [Abstract][Full Text] [Related]
46. Intermittent medication--an alternative?
Gaebel W
Acta Psychiatr Scand Suppl; 1994; 382():33-8. PubMed ID: 7916527
[TBL] [Abstract][Full Text] [Related]
47. Good medical practice in antipsychotic pharmacotherapy.
Peuskens J
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
[TBL] [Abstract][Full Text] [Related]
48. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
Shriqui CL
Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
[TBL] [Abstract][Full Text] [Related]
49. Intermittent vs maintenance medication in schizophrenia. Two-year results.
Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
[TBL] [Abstract][Full Text] [Related]
50. Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.
Schooler NR; Keith SJ; Severe JB; Matthews SM
Psychiatr Q; 1995; 66(4):279-92. PubMed ID: 8584586
[TBL] [Abstract][Full Text] [Related]
51. Targeted neuroleptic medication.
Grey P
Am J Psychiatry; 1991 Nov; 148(11):1612-3. PubMed ID: 1681753
[No Abstract] [Full Text] [Related]
52. Determinants of medication compliance in schizophrenia: empirical and clinical findings.
Fenton WS; Blyler CR; Heinssen RK
Schizophr Bull; 1997; 23(4):637-51. PubMed ID: 9366000
[TBL] [Abstract][Full Text] [Related]
53. The Italian guidelines for early intervention in schizophrenia: development and conclusions.
De Masi S; Sampaolo L; Mele A; Morciano C; Cappello S; Meneghelli A; De Girolamo G
Early Interv Psychiatry; 2008 Nov; 2(4):291-302. PubMed ID: 21352163
[TBL] [Abstract][Full Text] [Related]
54. Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules.
Mouri A; Nagai T; Ibi D; Yamada K
Neurobiol Dis; 2013 May; 53():61-74. PubMed ID: 23142533
[TBL] [Abstract][Full Text] [Related]
55. Strategies for enhancing drug therapy of schizophrenia.
Schooler NR; Levine J
Am J Psychother; 1983 Oct; 37(4):521-32. PubMed ID: 6140869
[TBL] [Abstract][Full Text] [Related]
56. Continuous versus intermittent neuroleptic therapy in schizophrenia.
Jolley AG; Hirsch SR
Drug Saf; 1993 May; 8(5):331-9. PubMed ID: 8099290
[No Abstract] [Full Text] [Related]
57. Is interval medication a successful treatment regimen for schizophrenic patients with critical attitudes towards treatment?
Godemann F; Linden M; Gaebel W; Köpke W; Müller P; Müller-Spahn F; Tegeler J; Pietzcker A
Eur Psychiatry; 2003 Mar; 18(2):82-4. PubMed ID: 12711404
[TBL] [Abstract][Full Text] [Related]
58. A team approach to pharmacologic treatment of chronic schizophrenia.
Keith SJ; Starr S; Matthews SM
Hosp Community Psychiatry; 1984 Aug; 35(8):802-5. PubMed ID: 6148301
[TBL] [Abstract][Full Text] [Related]
59. Assessing efficacy of chronic therapy when disease is characterized by frequent relapses: the example of schizophrenia.
Morabia A; Ten Have T; Huguelet P; Ferrero F
J Clin Epidemiol; 2002 Apr; 55(4):350-7. PubMed ID: 11927202
[TBL] [Abstract][Full Text] [Related]
60. Is intermittent, early intervention medication an alternative for neuroleptic maintenance treatment?
Gaebel W
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():11-6. PubMed ID: 7622828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
